Phase II Study of Clinical Activity of Pegaspargase in Women With Relapsed or Refractory Epithelial Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer

NCT01313078 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

4

Enrollment

NIH

Sponsor class

Conditions

Ovarian Neoplasms
Fallopian Tube Neoplasms
Primary Peritoneal Neoplasms

Interventions

DRUG: Pegylated L-Asparaginase

Sponsor

National Cancer Institute (NCI)